Biat Group Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
38
- Stock Symbol
-
BST
- Investments
-
3
- Share Price
-
$0.34
- (As of Friday Closing)
Biat Group General Information
Description
Biotechnology Assets SA is a clinical-stage biopharmaceutical company developing and producing biological products for the pharmaceutical and veterinarian sectors. It specializes in the prevention and treatment of niche diseases, such as orphan disease, antigens for new-generation vaccines, feed additives, and probiotics. Adl Bionatur offers a portfolio of non-therapeutic and therapeutic products to tier 1 and tier 2 animal health companies. The company's pipeline products include BNT006, BNT007, BNT010, and others.
Contact Information
Website
www.biatgroup.comCorporate Office
- Avenida Del Desarrollo Tecnológico, 11
- Jerez De La Frontera
- 11591 Cadiz
- Spain
Corporate Office
- Avenida Del Desarrollo Tecnológico, 11
- Jerez De La Frontera
- 11591 Cadiz
- Spain
Biat Group Timeline
Biat Group Stock Performance
As of 06-Dec-2024, Biat Group’s stock price is $0.34. Its current market cap is $21.7M with 64.3M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.34 | $0.34 | $0.25 - $0.50 | $21.7M | 64.3M | 138K | -$0.05 |
Biat Group Financials Summary
As of 30-Jun-2024, Biat Group has a trailing 12-month revenue of $3.3M.
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 30,180 | 28,888 | 13,762 | 24,577 |
| Revenue | 3,305 | 3,897 | 2,748 | 3,648 |
| EBITDA | 296 | 5,515 | 473 | (35) |
| Net Income | (3,302) | 1,703 | (2,043) | (3,562) |
| Total Assets | 16,129 | 18,358 | 19,812 | 22,504 |
| Total Debt | 2,483 | 7,877 | 12,577 | 4,050 |
Biat Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biat Group Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Biat Group Patents
Biat Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2494617-B1 | Use of garvicin a as an antimicrobial product | Inactive | 15-Mar-2013 | ||
| ES-2494617-A1 | Use of garvicin a as an antimicrobial product | Active | 15-Mar-2013 | ||
| US-9486516-B2 | Formulations for non-invasive delivery of active proteins to an animal or human | Inactive | 22-Mar-2012 | ||
| US-20150273050-A1 | Formulations for non-invasive delivery of active proteins to an animal or human | Active | 22-Mar-2012 | A61K39/205 |
Biat Group Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Biat Group Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Biat Group Acquisitions (3)
Biat Group’s most recent deal was a Merger/Acquisition with ADL Biopharma. The deal was made on 01-May-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ADL Biopharma | 01-May-2018 | Merger/Acquisition | BPO/Outsource Services | ||
| ZIP Solutions | 28-Apr-2016 | Merger/Acquisition | Biotechnology | ||
| Biobide | 04-Jun-2014 | Merger/Acquisition | Biotechnology |
Biat Group Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| ZIP Solutions | Biotechnology | Barcelona, Spain | 2015 |
| Biobide | Biotechnology | San Sebastian, Spain |
Biat Group Exits (1)
Biat Group’s most recent exit was on 01-May-2018 from ADL Biopharma. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| ADL Biopharma | 01-May-2018 | Completed |
|
Biat Group FAQs
-
When was Biat Group founded?
Biat Group was founded in 2005.
-
Where is Biat Group headquartered?
Biat Group is headquartered in Cadiz, Spain.
-
What is the size of Biat Group?
Biat Group has 38 total employees.
-
What industry is Biat Group in?
Biat Group’s primary industry is Pharmaceuticals.
-
Is Biat Group a private or public company?
Biat Group is a Public company.
-
What is Biat Group’s stock symbol?
The ticker symbol for Biat Group is BST.
-
What is the current stock price of Biat Group?
As of 06-Dec-2024 the stock price of Biat Group is $0.34.
-
What is the current market cap of Biat Group?
The current market capitalization of Biat Group is $21.7M.
-
What is Biat Group’s current revenue?
The trailing twelve month revenue for Biat Group is $3.3M.
-
What is Biat Group’s annual earnings per share (EPS)?
Biat Group’s EPS for 12 months was -$0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
